About this journal

Aims and scope

The International Journal of Chronic Obstructive Pulmonary Disease is an international, peer-reviewed journal of therapeutics and pharmacology focusing on concise rapid reporting of clinical studies and reviews in COPD. Special focus will be given to the pathophysiological processes underlying the disease, intervention programs, patient focused education, and self management protocols. This journal is directed at specialists and healthcare professionals.

All meta-analyses require a pre-submission check prior to submitting to the International Journal of Chronic Obstructive Pulmonary Disease. Please complete the pre-submission check form here.

Journal metrics

Usage

  • 397K annual downloads/views

Citation metrics

  • 2.7 (2023) Impact Factor
  • Q2 Impact Factor Best Quartile
  • 2.9 (2023) 5 year IF
  • 5.1 (2023) CiteScore (Scopus)
  • Q1 CiteScore Best Quartile
  • 0.978 (2023) SNIP
  • 0.954 (2023) SJR

Editorial board

Editor-in-Chief:

Dr Richard Russell, Respiratory Medicine, Nuffield Dept of Medicine, University of Oxford, United Kingdom

Associate Editors-in-Chief:

Dr Jill Ohar, Wake Forest School of Medicine, North Carolina, United States

Professor Min Zhang, Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jioa Tong University School of Medicine, China Mainland (PRC)

Editorial Board:

Dr Ahmad R. Alsayed, Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman, Jordon

Professor Aladin Boriek, Pulmonary and Critical Care/Medicine, Baylor College of Medicine, United States

Professor Mario Cazzola, Experimental Medicine and Surgery, University of Rome Tor Vergata, Italy

Dr Dennis Doherty, Division of Pulmonary and Critical Care Medicine, University of Kentucky, United States

Dr Edward Eden, Division of Pulmonary, Critical Care & Sleep Medicine, Icahn School of Medicine, United States

Dr Meilan Han, Department of Internal Medicine, University Of Michigan, United States

Dr Hwa Mu Lee, Medicine, Pulmonary and Critical care, University of California at Irvine, United States

Dr Marc Miravitlles, Pneumology Department, Hospital Universitari Vall d'Hebron, Spain

Professor Brooke Mossman, Pathology, University of Vermont College of Medicine, United States

Professor Ian D. Pavord, Respiratory Medicine, University of Oxford, United Kingdom

Dr Aldo Pezzuto, Cardiovascular-Respiratory Sciences, S Andrea Hospital-Sapienza University, Italy

Professor David B Price, Observational and Pragmatic Research Institute, Observational and Pragmatic Research Institute, Singapore, Singapore; Optimum Patient Care, Cambridg, Singapore

Professor Jennifer K Quint, National Heart and Lung Institute, Imperial College London, United Kingdom

Dr Alejandra Ramirez Venegas, Department of Tobacco Smoking and COPD Research, Instituto Nacional de Enfermedades Respiratorias, Mexico

Professor Paola Rogliani, Respiratory Medicine, Department of Experimental Medicine, University of Rome Tor Vergata, Italy

Professor Robert A Stockley, Lung function and Sleep, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, United Kingdom

Professor Theodoros Vassilakopoulos, Professor, Pulmonary & Critical Care Medicine, National & Kapodistrian University of Athens, Director, 2nd Department of Pulmonary Medicine Director, 2nd Department of Pulmonary Medicine Director, Department of Critical Care Medicine, Henry Dunant Hospital Center, Athens, Greece, Adjunct Professor, McGill University, Montreal, QC, Canada

Abstracting and indexing

International Journal of Chronic Obstructive Pulmonary Disease is indexed/tracked/covered by the following services:

Directory of Open Access Journals (DOAJ)

EMBASE (Elsevier)

Journal Citation Reports/Science Edition

Pubmed (NLM)

PubMed Central Selective Deposit Medicine & Health (NLM)

Science Citation Index Expanded (Clarivate Analytics)

Scopus (Elsevier)

Open access

International Journal of Chronic Obstructive Pulmonary Disease is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.

Why choose open access?

  1. Increase the discoverability and readership of your article
  2. Make an impact and reach new readers, not just those with easy access to a research library
  3. Freely share your work with anyone, anywhere
  4. Comply with funding mandates and meet the requirements of your institution, employer or funder
  5. Rigorous peer review for every open access article

Article Publishing Charges (APC)

To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.

Use our APC finder to calculate your article publishing charge

News, offers and calls for papers

Ready to submit?

Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window) Instructions for authors